Researchers from the University of Iowa and University of Texas Southwestern Medical Center studied the genetics of two families severely affected by eating disorders and found two gene mutations, one in each family, that are associated with increased risk of developing eating disorders.
The study also showed that the two genes interact in the same signalling pathway in the brain, and that the two mutations produce the same biological effect.
The findings suggest that this pathway might represent a new target for understanding and potentially treating eating disorders.
In the new study, 20 members from three generations of one family (10 individuals affected by eating disorders and 10 unaffected), and eight members of a second family (six affected and two unaffected) were analysed.
The gene discovered in the larger family was ESRRA, a transcription factor that turns on the expression of other genes. The mutation associated with eating disorders decreases ESSRA activity.
The gene found in the second family is a transcriptional repressor called histone deacetylase 4 (HDAC4), which turns off transcription factors, including ESRRA.
Importantly, the team also found that the two affected proteins interacted with one another; HDAC4 binds to ESRRA and inhibits it.
The two genes are already known to be involved in metabolic pathways in muscle and fat tissue. They also are both regulated by exercise.
In the brain, HDAC4 is very important for regulating genes that form connections between neurons. However, there's almost nothing known about ESRRA in the brain, although it is expressed in many brain regions that are disrupted in anorexia.
The study was published in the Journal of Clinical Investigation.
